Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H25NS |
| Molecular Weight | 299.474 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C1CCN(CC1)C2(CCCCC2)C3=CC4=CC=CC=C4S3
InChI
InChIKey=RGSVXQJPSWZXOP-UHFFFAOYSA-N
InChI=1S/C19H25NS/c1-5-11-19(12-6-1,20-13-7-2-8-14-20)18-15-16-9-3-4-10-17(16)21-18/h3-4,9-10,15H,1-2,5-8,11-14H2
| Molecular Formula | C19H25NS |
| Molecular Weight | 299.474 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:07:50 GMT 2025
by
admin
on
Mon Mar 31 22:07:50 GMT 2025
|
| Record UNII |
Q1WR6UP7MW
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-Benocyclidine
Created by
admin on Mon Mar 31 22:07:50 GMT 2025 , Edited by admin on Mon Mar 31 22:07:50 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
100000175580
Created by
admin on Mon Mar 31 22:07:50 GMT 2025 , Edited by admin on Mon Mar 31 22:07:50 GMT 2025
|
PRIMARY | |||
|
112726-66-6
Created by
admin on Mon Mar 31 22:07:50 GMT 2025 , Edited by admin on Mon Mar 31 22:07:50 GMT 2025
|
PRIMARY | |||
|
Benocyclidine
Created by
admin on Mon Mar 31 22:07:50 GMT 2025 , Edited by admin on Mon Mar 31 22:07:50 GMT 2025
|
PRIMARY | Benocyclidine, also known as benzothiophenylcyclohexylpiperidine(BTCP), is a psychoactive recreational drug of the arylcyclohexylamine class which is related to phencyclidine(PCP). It was first described in a patent application naming Marc Caron and colleagues at Duke University in 1997. It acts as a potent and selective dopamine reuptake inhibitor (DRI) and a psychostimulant.[2][3] Unlike related compounds like phencyclidine and ketamine, benocyclidine is a pure DRI with negligible affinity for the NMDA receptor, and it therefore lacks any anticonvulsant, anesthetic, hallucinogenic, or dissociative effects. It has been used to label the dopamine transporter. BCP was also used to try to find a common pharmacophore for DRI type stimulants. More recently, benocyclidine has been found in several ecstasy tablets, sold as MDMA. | ||
|
123692
Created by
admin on Mon Mar 31 22:07:50 GMT 2025 , Edited by admin on Mon Mar 31 22:07:50 GMT 2025
|
PRIMARY | |||
|
Q1WR6UP7MW
Created by
admin on Mon Mar 31 22:07:50 GMT 2025 , Edited by admin on Mon Mar 31 22:07:50 GMT 2025
|
PRIMARY | |||
|
DTXSID0042581
Created by
admin on Mon Mar 31 22:07:50 GMT 2025 , Edited by admin on Mon Mar 31 22:07:50 GMT 2025
|
PRIMARY | |||
|
BENOCYCLIDINE
Created by
admin on Mon Mar 31 22:07:50 GMT 2025 , Edited by admin on Mon Mar 31 22:07:50 GMT 2025
|
PRIMARY | Benzocyclidine (BCP) is a derivative of phencyclidine with a benzothiophenyl group instead of a phenyl ring. It acts as a potent and selective dopamine reuptake inhibitor (IC50 = 8 nM) with negligible affinity for the NMDA receptor-linked phencyclidine receptor (K0.5 = 6 μM).1,2 BCP has been used to label the dopamine transporter in the mouse brain.3 This product is intended for forensic and research applications. | ||
|
64145
Created by
admin on Mon Mar 31 22:07:50 GMT 2025 , Edited by admin on Mon Mar 31 22:07:50 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
TARGET -> INHIBITOR |
BINDING
IC50
|
||
|
LABELED -> NON-LABELED |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
